Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons - PubMed (original) (raw)

• PMID: 2430188
• DOI: 10.1038/323819a0

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

G H Wong et al. Nature. 1986.

Abstract

Tumour necrosis factor (TNF) and lymphotoxin were initially described as tumoricidal proteins that are produced by activated macrophages and lymphocytes, respectively. Since TNF and lymphotoxin are structurally related, bind to the same cell surface receptor and have indistinguishable biological activities, they have been designated as TNF-alpha and TNF-beta, respectively. The multiple activities of these molecules indicate their importance in immunoregulative responses. Here we report that both TNF-alpha and TNF-beta have antiviral activity and synergize with interferons (IFNs) in the induction of resistance to both RNA and DNA virus infection in diverse cell types. These effects of TNFs are not due to the induction of IFN synthesis. Virus-infected cells are selectively killed by TNFs and this activity is accelerated by IFN-gamma. The production of TNFs is induced by viruses, further suggesting the importance of TNFs in the physiological antiviral response.

PubMed Disclaimer

Similar articles

• Human cytokines, tumor necrosis factor, and interferons: gene cloning, animal studies, and clinical trials.
  Bollon AP, Berent SL, Torczynski RM, Hill NO, Lemeshev Y, Hill JM, Jia FL, Joher A, Pichyangkul S, Khan A. Bollon AP, et al. J Cell Biochem. 1988 Apr;36(4):353-67. doi: 10.1002/jcb.240360405. J Cell Biochem. 1988. PMID: 2454238
• Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
  Gill N, Deacon PM, Lichty B, Mossman KL, Ashkar AA. Gill N, et al. J Virol. 2006 Oct;80(20):9943-50. doi: 10.1128/JVI.01036-06. J Virol. 2006. PMID: 17005672 Free PMC article.
• Antiviral effects of recombinant human tumor necrosis factor.
  Ito M, O'Malley JA. Ito M, et al. Lymphokine Res. 1987 Fall;6(4):309-18. Lymphokine Res. 1987. PMID: 2448553
• Inhibition of tumor necrosis factor and interferon triggered responses by DNA viruses.
  Krajcsi P, Wold WS. Krajcsi P, et al. Semin Cell Dev Biol. 1998 Jun;9(3):351-8. doi: 10.1006/scdb.1998.0244. Semin Cell Dev Biol. 1998. PMID: 9665872 Review.
• Interferon-induced proteins and the antiviral state.
  Staeheli P. Staeheli P. Adv Virus Res. 1990;38:147-200. doi: 10.1016/s0065-3527(08)60862-3. Adv Virus Res. 1990. PMID: 1699395 Review. No abstract available.

Cited by

• B cells modulate lung antiviral inflammatory responses via the neurotransmitter acetylcholine.
  Baumgarth N, Prieto AC, Luo Z, Kulaga H. Baumgarth N, et al. Res Sq [Preprint]. 2024 Jun 25:rs.3.rs-4421566. doi: 10.21203/rs.3.rs-4421566/v1. Res Sq. 2024. PMID: 38978583 Free PMC article. Preprint.
• Novel Fermentates Can Enhance Key Immune Responses Associated with Viral Immunity.
  Finnegan D, Mechoud MA, FitzGerald JA, Beresford T, Mathur H, Cotter PD, Loscher C. Finnegan D, et al. Nutrients. 2024 Apr 19;16(8):1212. doi: 10.3390/nu16081212. Nutrients. 2024. PMID: 38674902 Free PMC article.
• A pairwise cytokine code explains the organism-wide response to sepsis.
  Takahama M, Patil A, Richey G, Cipurko D, Johnson K, Carbonetto P, Plaster M, Pandey S, Cheronis K, Ueda T, Gruenbaum A, Kawamoto T, Stephens M, Chevrier N. Takahama M, et al. Nat Immunol. 2024 Feb;25(2):226-239. doi: 10.1038/s41590-023-01722-8. Epub 2024 Jan 8. Nat Immunol. 2024. PMID: 38191855 Free PMC article.
• Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection.
  Fletcher P, O'Donnell KL, Doratt BM, Malherbe DC, Clancy CS, Rhoderick JF, Feldmann F, Hanley PW, Ksiazek TG, Geisbert TW, Messaoudi I, Marzi A. Fletcher P, et al. Emerg Microbes Infect. 2023 Dec;12(2):2239950. doi: 10.1080/22221751.2023.2239950. Emerg Microbes Infect. 2023. PMID: 37470396 Free PMC article.
• The Impact of b/tsDMARD Dose Reduction on Chronic Hepatitis B in Rheumatoid Arthritis Patients: A Two-Center Long-Term Safety Analysis.
  Chen DY, Chen HH, Chang SH, Chen YM, Huang PH, Hsieh CW, Lan JL, Tang KT. Chen DY, et al. J Clin Med. 2022 Dec 22;12(1):86. doi: 10.3390/jcm12010086. J Clin Med. 2022. PMID: 36614890 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database